Skip to content

ZIMMER BIOMET HOLDINGS, INC.

ZBH · XNYS

CIK 1136869fmd_1QHT7BWA8XX4ZBZN6MFPPAXKG1Manufacturing · Orthopedic, Prosthetic & Surgical Appliances & SuppliesTemplate: Standard

Coverage: Jan 01, 2007 to Sep 30, 2026, 75 periods

Income Statement · Annual · Millions · USD
Line itemFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Total revenues7,6687,8037,9336,9616,1286,8276,9407,3947,6798,232
Cost of revenue2,3822,1332,2721,9441,8241,9602,0202,0842,1912,494
Net interest income(355)(325)(289)(227)(212)(208)(165)(201)(218)(293)
Gross profit5,2875,6705,6615,0174,3034,8674,9205,3105,4875,738
Realized investment gains (losses)––––––(117)(19)(42)15
Research and development366370392394323436406459437459
Selling, general and administrative2,9453,1053,3792,8102,7132,8432,7622,8392,9303,257
Total operating expenses––––––––––
Operating income821799341,112838606961,2781,2861,098
Interest expense358328––––––––
Interest and investment income32––––––––
Other non-operating income (expense)(67)(9)(16)(5)2412(128)(9)(31)26
Income before taxes400465(271)880(105)4994041,0671,037831
Income tax expense95(1,349)108(238)(96)5411242131126
Net income from continuing operations3051,813(379)1,118(9)4462911,025905705
Net income3061,814(379)1,132(139)4022311,024904705